Key result
Isoproterenol testing induced a significantly higher incidence of polymorphic ventricular arrhythmias compared to exercise testing in newly diagnosed ARVC patients (89.2% vs. 43.2%, P<0.0001).
Why the study?
Does isoproterenol testing improve the detection of polymorphic ventricular arrhythmias compared to exercise testing in newly diagnosed ARVC patients?
Population
37 newly diagnosed arrhythmogenic right ventricular cardiomyopathy patients and a control group referred for…
Comparison
Isoproterenol testing vs Exercise testing
Design
Cohort
Authors
Loading...
Isoproterenol testing may unmask more arrhythmias than exercise in early ARVC; leaves open its added value for risk stratification.
Cross-Sectional (n=37)
Does isoproterenol testing improve the detection of polymorphic ventricular arrhythmias compared to exercise testing in newly diagnosed ARVC patients?
Absolute Event Rate: 89.2% vs 43.2%
p-value: p=< 0.0001
Isoproterenol testing is significantly more arrhythmogenic than exercise testing in newly diagnosed ARVC patients, suggesting it may have superior diagnostic utility for detecting characteristic ventricular arrhythmias.
Denis et al. (2018) conducted a cross-sectional in Arrhythmogenic right ventricular cardiomyopathy (ARVC) (n=37). Isoproterenol testing vs. Exercise testing was evaluated on Incidence of polymorphic ventricular arrhythmias (p=< 0.0001). Isoproterenol testing induced a significantly higher incidence of polymorphic ventricular arrhythmias compared to exercise testing in newly diagnosed ARVC patients (89.2% vs. 43.2%, P<0.0001).